| Ident. | Authors (with country if any) | Title |
|---|
| 003513 |
M. D. Griffith [Australie, France] ; M. C. Thompson [Australie] ; T. Leweke [France] ; K. Hourigan [Australie] ; W. P. Anderson [Australie] | Wake behaviour and instability of flow through a partially blocked channel |
| 003519 |
Victor F. Tapson [États-Unis] ; Hervé Decousus [France] ; Mario Pini [Italie] ; Beng H. Chong [Australie] ; James B. Froehlich [États-Unis] ; Manuel Monreal [Espagne] ; Alex C. Spyropoulos [États-Unis] ; Geno J. Merli [États-Unis] ; Rainer B. Zotz [Allemagne] ; Jean-Francois Bergmann [France] ; Ricardo Pavanello [Brésil] ; Alexander G. G. Turpie [Canada] ; Mashio Nakamura [Japon] ; Franco Piovella [Italie] ; Ajau K. Kakkar [Royaume-Uni] ; Frederick A. Spencer [États-Unis] ; Gordon Fitzgerald [États-Unis] ; Frederick A. Jr Anderson [États-Unis] | Venous thromboembolism prophylaxis in acutely III hospitalized medical patients : Findings from the international medical prevention registry on venous thromboembolism |
| 003550 |
Giuseppe Mancia [Italie] ; Pascal Bousquet [France] ; Jean Luc Elghozi [France] ; Murray Esler [Australie] ; Guido Grassi [Italie] ; Stevo Julius [États-Unis] ; John Reid [Royaume-Uni] ; Peter A. Van Zwieten [Pays-Bas] | The sympathetic nervous system and the metabolic syndrome |
| 003734 |
Henry Krum [Australie] ; Richard E. Gilbert [Canada, Australie] ; Joël Menard [France] | Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders. Commentary |
| 003775 |
Leopold Fezeu [France, Cameroun] ; Beverley Balkau [France] ; André-Pascal Kengne [Cameroun, Australie] ; Eugène Sobngwi [Cameroun] ; Jean-Claude Mbanya [Cameroun] | Metabolic syndrome in a sub-Saharan African setting: Central obesity may be the key determinant |
| 003817 |
Beverley Balkau [France] ; John E. Deanfield [Royaume-Uni] ; Jean-Pierre Despres [Canada] ; Jean-Pierre Bassand [France] ; Keith A. A. Fox [Royaume-Uni] ; Sidney C. Jr Smith [États-Unis] ; Philip Barter [Australie] ; Chee-Eng Tan [Singapour] ; Luc Van Gaal [Belgique] ; Hans-Ulrich Wittchen [Allemagne] ; Christine Massien [France] ; Steven M. Haffner [États-Unis] | International day for the evaluation of abdominal obesity (IDEA) : A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168 000 primary care patients in 63 countries |
| 003862 |
Philip Barter [Australie] ; Antonio M. Gotto [États-Unis] ; John C. Larosa [États-Unis] ; Jaman Maroni [États-Unis] ; Michael Szarek [États-Unis] ; Scott M. Grundy [États-Unis] ; John J. P. Kastelein [États-Unis] ; Vera Bittner [États-Unis] ; Jean-Charles Fruchart [France] | HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events |
| 003991 |
E. Marijon [Mozambique, France] ; L. Trinquart [France] ; D. Jani [Mozambique] ; H. Jourdier [Mozambique] ; E. Garbarz [France] ; A. O. Mocumbi [Mozambique] ; D. S. Celermajer [Australie] ; B. Ferreira [Mozambique] | Coronary heart disease and associated risk factors in sub-Saharan Africans |
| 003A21 |
Paul Elliott [Royaume-Uni] ; Lesley L. Walker [Australie] ; Mark P. Little [Royaume-Uni] ; John R. Blair-West [Australie, États-Unis] ; Robert E. Shade [États-Unis] ; D. Rick Lee [États-Unis] ; Pierre Rouquet [Gabon] ; Eric Leroy [Gabon] ; Xavier Jeunemaitre [France] ; Raymond Ardaillou [France] ; Francoise Paillard [France] ; Pierre Meneton [France] ; Derek A. Denton [États-Unis, Australie] | Change in salt intake affects blood pressure of chimpanzees : Implications for human populations |
| 003A25 |
Philippe Gosse [France] ; Georgios Papaioanou [France] ; Paul Coulon [France] ; Sylvain Reuter [France] ; Philippe Lemetayer [France] ; Michel Safar [France] ; Michael F. O'Rourke [Australie] | Can ambulatory blood-pressure monitoring provide reliable indices of arterial stiffness? |
| 003A47 |
Robyn J. Tapp [France, Australie] ; Beverley Balkau [France] ; Jonathan E. Shaw [Australie] ; Paul Valensi [France] ; Martine Cailleau [France] ; Eveline Eschwege [France] | Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease : The DESIR study |
| 003A94 |
Didier Blanchard [France] ; Gian Battista Danzi [Italie] ; Philip Urban [Suisse] ; Morris Moseri [Israël] ; Craig Juergens [Australie] ; Philip Guyon [France] ; Bernd Nowak [Allemagne] ; Damras Tresucosol [Thaïlande] ; Maarten J. Suttorp [Pays-Bas] ; Ahmad Farshid [Australie] ; Ran Kornowski [Israël] ; Eulogio Garcia [Espagne] ; Richard Yeend [Australie] ; Hirofumi Nagai [Japon] ; Dragica Paunovic [Belgique] | A novel ultra-thin bare metal stent (BMS) : results from a worldwide registry |
| 003D31 |
John Chalmers [Australie] ; Nikola Sprigg [Royaume-Uni] ; Laura J. Gray [Royaume-Uni] ; Philip M. W. Bath [Royaume-Uni] ; Gudrun Boysen [Danemark] ; Peter Paul De Deyn [Belgique] ; Pal Friis [Norvège] ; Didier Leys [France] ; Reijo Marttila [Finlande] ; Jan-Edwin Olsson [Suède] ; Desmond O'Neill [Irlande (pays)] ; Bernd Ringelstein [Allemagne] ; Jan-Jacob Van Der Sande [Pays-Bas] ; Ewa Lindenstr M [Danemark] | Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke : data from the TAIST trial. Commentary |
| 003D32 |
Olivier Hanon [France] ; Renaud Pequignot [France] ; Marie Laure Seux [France] ; Hermine Lenoir [France] ; Alexandra Bune [Australie] ; Anne Sophie Rigaud [France] ; Francoise Forette [France] ; Xavier Girerd [France] | Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints |
| 003D55 |
F. Zannad [France] ; M. Kessler [France] ; P. Lehert [Australie, Belgique] ; J. P. Grünfeld [France] ; C. Thuilliez [France] ; A. Leizorovicz [France] ; P. Lechat [France] | Prevention of cardiovascular events in end-stage renal disease : Results of a randomized trial of fosinopril and implications for future studies |
| 003F04 |
Hisatomi Arima [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Craig Anderson [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Stephen Davis [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] | Lower target blood pressures are safe and effective for the prevention of recurrent stroke : the PROGRESS trial |
| 004048 |
Michael F. O'Rourke [Australie] ; Stanley S. Franklin [États-Unis] ; Stephane Laurent [France] ; John Cockcroft [Royaume-Uni] ; Luc Van Bortel [Belgique] ; Pierre Boutouyrie [France] ; Cristina Giannattasio [Italie] ; Daniel Hayoz [Suisse] ; Bruno Pannier [France] ; Charalambos Vlachopoulos [Grèce] ; Ian Wilkinson [Royaume-Uni] ; Harry Struijker-Boudier [Pays-Bas] | Expert consensus document on arterial stiffness : methodological issues and clinical applications. Commentary |
| 004085 |
Patrick W. G. Mallon [Australie] ; John Miller [Australie] ; Jason C. Kovacic [Australie] ; Julia Kent-Hughes [Australie] ; Richard Norris [Australie] ; Katherine Samaras [Australie, France] ; Michael P. Feneley [Australie] ; David A. Cooper [Australie] ; Andrew Carr [Australie] ; Shahin Gharakhanian [France, États-Unis] ; Franck Boccara [France] ; Jacqueline Capeau [France] | Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men : a randomized, placebo-controlled study. Commentary |
| 004183 |
Carlene M. M. Lawes [Nouvelle-Zélande] ; Stephen Vander Hoorn [Nouvelle-Zélande] ; Malcolm R. Law [Royaume-Uni] ; Paul Elliott [Royaume-Uni] ; Stephen Macmahon [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Francois Gueyffier [France] ; James Wright [Canada] | Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. Commentary |
| 004198 |
P. J. Barter [Australie] ; C. M. Ballantyne [États-Unis] ; R. Carmena [Espagne] ; M. Castro Cabezas [Pays-Bas] ; M. John Chapman [France] ; P. Couture [Canada] ; J. De Graaf [Pays-Bas] ; P. N. Durrington [Royaume-Uni] ; O. Faergeman [Danemark] ; J. Frohlich [Canada] ; C. D. Furberg [États-Unis] ; C. Gagne [Canada] ; S. M. Haffner [États-Unis] ; S. E. Humphries [Royaume-Uni] ; I. Juncner [Suède] ; R. M. Krauss ; P. Kwiterovich ; S. Marcovina ; C. J. Packard ; T. A. Pearson ; K. Srinath Reddy ; R. Rosenson ; N. Sarrafzadegan ; A. D. Sniderman ; A. F. Stalenhoef [Pays-Bas] ; E. Stein ; P. J. Talmud [Royaume-Uni] ; A. M. Tonkin ; G. Walldius ; K. M. S. Williams [États-Unis] | Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy : report of the thirty-person/tencountry panel |
| 004305 |
Howard J. Eisen [États-Unis] ; Jon Kobashigawa [États-Unis] ; Anne Keogh [Australie] ; Robert Bourge [États-Unis] ; Dale Renlund [États-Unis] ; Robert Mentzer [États-Unis] ; Edwin Alderman [États-Unis] ; Hannah Valantine [États-Unis] ; Georges Dureau [France] ; Donna Mancini [États-Unis] ; Richard Mamelok [États-Unis] ; Robert Gordon [États-Unis] ; Whedy Wang [États-Unis] ; Mandeep Mehra [États-Unis] ; Maria Rosa Constanzo [États-Unis] ; Manfred Hummel [Allemagne] ; Jay Johnson [États-Unis] | Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients |
| 004405 |
Bruce Neal [Australie] ; Athanase Benetos [France] ; Frédérique Thomas [France] ; Kathryn E. Bean [France] ; Bruno Pannier [France] ; Louis Guize [France] | Role of modifiable risk factors in life expectancy in the elderly. Commentary |
| 004572 |
DONG YOU [France] ; Laurent Loufrani [France] ; Celine Baron [France] ; Bernard I. Levy [France] ; Robert E. Widdop [Australie] ; Daniel Henrion [France] | High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats |
| 004579 |
B. K. Kr Mer [Allemagne] ; H.-H. Neumayer [Allemagne] ; R. Stahl [Allemagne] ; M. Pietrzyk [Allemagne] ; B. Krüger [Allemagne] ; B. Pfalzer [Allemagne] ; B. Bourbigot [France] ; S. Campbell [Australie] ; J. Whelchel [États-Unis] ; J. Eris [Australie] ; S. Vitko [République tchèque] ; K. Budde [Allemagne] | Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab |
| 004640 |
Carole Dufouil [France] ; John Chalmers [Australie] ; Oguzhan Coskun [France] ; Véronique Besancon [France] ; Marie-Germaine Bousser [France] ; Pierre Guillon [France] ; Stephen Macmahon [Australie] ; Bernard Mazoyer [France] ; Bruce Neal [Australie] ; Mark Woodward [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Christophe Tzourio [France, Australie] | Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy |
| 004642 |
Ronnie Willenheimer [Suède] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Bernard Silke [Irlande (pays)] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Allan Skene [Royaume-Uni] ; Louis Van De Ven [Allemagne] ; Patricia Verkenne [Allemagne] ; Philippe Lechat [France] | Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence : Results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III |
| 004731 |
Athanase Benetos [France] ; Oscar H. Franco [Pays-Bas] ; Anna Peeters [Australie] ; Luc Bonneux [Belgique] ; Chris De Laet [Pays-Bas, Belgique] | Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women : Life course analysis. Commentary |
| 004743 |
Alex Bobik [Australie] ; Philippe Hudlett [France] ; Agnès Neuville [France] ; Anne Miternique [France] ; Christophe Griffon [France] ; Denis Weltin [France] ; Dominique Stephan [France] | Angiogenesis and arteriogenesis are increased in fibrin gel chambers implanted in prehypertensive spontaneously hypertensive rats |
| 004867 |
Jean-Michel Mallion [France] ; Bernard Chamontin [France] ; Roland Asmar [France] ; Peter Wilhelmus De Leeuw [Pays-Bas] ; Eoin O'Brien [Irlande (pays)] ; Daniel Duprez [Belgique, États-Unis] ; Michael F. O'Rourke [Australie] ; Karl-Heinz Rahn [Allemagne] ; Ramon Romero [Espagne] ; Edouard Battegay [Suisse] ; Gerhart Hitzenberger [Autriche] ; Michel E. Safar [France] | Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: The REASON study |
| 004901 |
Pierre Youinou [France] ; Yves Renaudineau [France] | The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases |
| 004917 |
Douglas L. Mann [États-Unis] ; John J. V. Mcmurray [Royaume-Uni] ; Milton Packer [États-Unis] ; Karl Swedberg [Suède] ; Jeffrey S. Borer [États-Unis] ; Wilson S. Colucci [France] ; Jacques Djian [France] ; Helmut Drexler [Allemagne] ; Arthur Feldman [États-Unis] ; Lars Kober [Danemark] ; Henry Krum [Australie] ; Peter Liu [Canada] ; Markku Nieminen [Finlande] ; Luigi Tavazzi [Italie] ; Dirk Jan Van Veldhuisen [Pays-Bas] ; Anders Waldenstrom [Suède] ; Marshelle Warren [États-Unis] ; Arne Westheim [Norvège] ; Faiez Zannad [France] ; Thomas Fleming [États-Unis] | Targeted anticytokine therapy in patients with chronic Heart failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) |
| 004931 |
Pierre Amarenco [France] ; Andrew M. Tonkin [Australie] | Statins for stroke prevention : Disappointment and hope |
| 004947 |
Nicola De Luca [Italie] ; Roland G. Asmar [France] ; Gérard M. London [France] ; Michael F. O'Rourke [Australie] ; Michel E. Safare [France] | Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects |
| 004960 |
Bo Eklöf [Suède] ; Robert B. Rutherford [États-Unis] ; John J. Bergan [France] ; Patrick H. Carpentier [France] ; Peter Gloviczki [États-Unis] ; Robert L. Kistner [États-Unis] ; Mark H. Meissner [États-Unis] ; Gregory L. Moneta [États-Unis] ; Kenneth Myers [Australie] ; Frank T. Padberg [États-Unis] ; Michel Perrin [France] ; C. Vaughan Ruckley [Royaume-Uni] ; Philip Coleridge Smith [Royaume-Uni] ; Thomas W. Wakefield [États-Unis] | Revision of the CEAP classification for chronic venous disorders: Consensus statement |
| 004964 |
Jacques Amar [France] ; Jean-Bernard Ruidavets [France] ; Claire Bal Dit Sollier [France] ; Vanina Bongard [France] ; Henri Boccalon [France] ; Bernard Chamontin [France] ; Ludovic Drouet [France] ; Jean Ferrieres [France] ; Alberto Avolio [Australie] | Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness. Commentary |
| 004966 |
Nicola De Luca [Italie] ; Jean-Michel Mallion [France] ; Michael F. O'Rourke [Australie] ; Eoin O'Brien [Irlande (pays)] ; Karl-Heinz Rahn [Allemagne] ; Bruno Trimarco [Italie] ; Ramon Romero [Espagne] ; Peter Wilhelmus De Leeuw [Pays-Bas] ; Gerhart Hitzenberger [Autriche] ; Edouard Battegay [Suisse] ; Daniel Duprez [Belgique] ; Peter Sever [Royaume-Uni] ; Michel E. Safar [France] | Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: The REASON echocardiography study |
| 004A07 |
Véronique Regnault [France] ; H. Coenraad Hemker [Pays-Bas] ; Denis Wahl [France] ; Thomas Lecompte [France] | Phenotyping the haemostatic system by thrombography: potential for the estimation of thrombotic risk |
| 004A11 |
Anthony Rodgers [Nouvelle-Zélande] ; Neil Chapman [Australie] ; Mark Woodward [Australie] ; Li-Sheng Liu [République populaire de Chine] ; Sam Colman [Australie] ; Arier Lee [Nouvelle-Zélande] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Francois Gueyffier [France] | Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Commentary |
| 004A60 |
Angela Tincani [Italie] ; Flavio Allegri [Italie] ; Genesio Balestrieri [Italie] ; Guido Reber [Suisse] ; Marielle Sanmarco [France] ; Pierluigi Meroni [Italie] ; Marie-Claire Boffa [France] | Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European forum on antiphospholipid antibodies |
| 004B68 |
Herbert Schuster [Allemagne] ; Philip J. Barter [Australie] ; Steen Stender [Danemark] ; Raphael C. Cheung [Canada] ; Jacques Bonnet [France] ; Jonathan M. Morrell [Royaume-Uni] ; Claire Watkins [Royaume-Uni] ; David Kallend [Royaume-Uni] ; Ali Raza [Royaume-Uni] | Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study |
| 004C18 |
K. Borch-Johnsen [Danemark] ; S. Colagiuri [Australie] ; B. Balkau [France] ; C. Glümer [Danemark] ; B. Carstensen [Danemark] ; A. Ramachandran [Inde] ; Y. Dong [République populaire de Chine] ; W. Gao [République populaire de Chine] | Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia |
| 004D77 |
P. Zimmet [Australie] | The burden of type 2 diabetes: are we doing enough? |
| 005047 |
Nina Friis-M Ller [Danemark] ; Rainer Weber [Suisse] ; Peter Reiss [Pays-Bas] ; Rodolphe Thiebaut [France] ; Ole Kirk [Danemark] ; Antonella D'Arminio Monforte [Italie] ; Christian Pradier [France] ; Linda Morfeldt [Suède] ; Silvia Mateu [Espagne] ; Matthew Law [Australie] ; Wafaa El-Sadr [États-Unis] ; Stephan De Wit [Belgique] ; Caroline A. Sabin [Royaume-Uni] ; Andrew N. Phillips [Royaume-Uni] ; Jens D. Lundgren [Danemark] | Cardiovascular disease risk factors in HIV patients -association with antiretroviral therapy. Results from the DAD study |
| 005210 |
Elisabeth A. Lambert [Australie] ; Jane Thompson [Australie] ; Markus Schlaich [Australie] ; Dominique Laude [France] ; Jean-Luc Elghozi [France] ; Murray D. Esler [Australie] ; Gavin W. Lambert [Australie] ; Guido Grassi [Italie] ; Wolfgang Kiowski [Suisse] | Sympathetic and cardiac baroreflex function in panic disorder. Commentary |
| 005300 |
Victor J. Dzau [États-Unis] ; Kenneth Bernstein [États-Unis] ; David Celermajer [Australie] ; Jerome Cohen [États-Unis] ; Björn Dahlöf [Suède] ; John Deanfield [Royaume-Uni] ; Javier Diez [Espagne] ; Helmut Drexler [Allemagne] ; Roberto Ferrari [Italie] ; Wiek Van Gilst [Pays-Bas] ; Lennart Hansson [Suède] ; Burkhard Hornig [Allemagne] ; Ahsan Husain [Australie] ; Colin Johnston [Australie] ; Harold Lazar [États-Unis] ; Eva Lonn [Canada] ; Thomas Lüscher [Suisse] ; John Mancini [Canada] ; Albert Mimran [France] ; Carl Pepine ; Ton Rabelink ; Willem Remme ; Luis Ruilope ; Marcel Ruzicka ; Heribert Schunkert ; Karl Swedber ; Thomas Unger ; Douglas Vaughan ; Michael Weber | Pathophysiologic and therapeutic importance of tissue ACE: A consensus report |
| 005C54 |
Pascal Bousquet [France] ; Monique Dontenwill [France] ; Hugues Greney [France] ; Josiane Feldman [France] | Imidazoline receptors in cardiovascular and metabolic diseases |
| 006495 |
XIA SHEN [République populaire de Chine] ; YONGJING XIA [France] ; C. Sass [France] ; S. Visvikis [France] ; G. Siest [France] | Association of apolipoprotein E polymorphism and concentration with serum lipids and apolipoprotein level in the Chinese from Shanghai |
| 006530 |
S. Cheng [États-Unis] ; C. Pallaud [France] ; M. A. Grow [États-Unis] ; S. J. Scharf [États-Unis] ; H. A. Erlich [États-Unis] ; W. Klitz [États-Unis] ; C. R. Pullinger [États-Unis] ; M. J. Malloy [États-Unis] ; J. P. Kane [États-Unis] ; G. Siest [France] ; S. Visvikis [France] | A multilocus genotyping assay for cardiovascular disease |
| 006571 |
A. Grynberg [France] ; F. Oudot [France] ; P. L. Mclennan [Australie] ; P. Athias [France] | Acides gras omega-3 et prévention cardiovasculaire |
